Cite
Administration of Spores of Nontoxigenic Clostridium difficile Strain M3 for Prevention of Recurrent C difficile Infection.
MLA
Gerding, Dale N., et al. “Administration of Spores of Nontoxigenic Clostridium Difficile Strain M3 for Prevention of Recurrent C Difficile Infection.” JAMA: Journal of the American Medical Association, vol. 313, no. 17, May 2015, pp. 1719–27. EBSCOhost, https://doi.org/10.1001/jama.2015.3725.
APA
Gerding, D. N., Meyer, T., Lee, C., Cohen, S. H., Murthy, U. K., Poirier, A., Van Schooneveld, T. C., Pardi, D. S., Ramos, A., Barron, M. A., Hongzi Chen, & Villano, S. (2015). Administration of Spores of Nontoxigenic Clostridium difficile Strain M3 for Prevention of Recurrent C difficile Infection. JAMA: Journal of the American Medical Association, 313(17), 1719–1727. https://doi.org/10.1001/jama.2015.3725
Chicago
Gerding, Dale N., Thomas Meyer, Christine Lee, Stuart H. Cohen, Uma K. Murthy, Andre Poirier, Trevor C. Van Schooneveld, et al. 2015. “Administration of Spores of Nontoxigenic Clostridium Difficile Strain M3 for Prevention of Recurrent C Difficile Infection.” JAMA: Journal of the American Medical Association 313 (17): 1719–27. doi:10.1001/jama.2015.3725.